Sunder Biomedical Tech. Co (4115) Fair Value & Analysis
Healthcare · TW · Market cap 466M TWD
Fair value as of: Jul 9, 2026
From 4 valuation models · updated today
Fair value updated Jul 9, 2026 — revised from 37.90 TWD to 10.30 TWD (−72.8%) since Jun 24, 2026. Share price +1.7% over the past month.
Price vs Fair Value (7 months)
7‑month range 6.75 TWD – 11.15 TWD · fair‑value band 6.54 TWD – 14.06 TWD · the 7.88 TWD price screens below the 10.30 TWD fair value. As of Jul 9, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Sunder Biomedical Tech. Co (4115) currently trades at 7.88 TWD, while our model-based Fair Value estimate is 10.30 TWD — implying the stock looks roughly 30.7% undervalued today. We read business quality at 41/100 (below-average quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.
Net debt stands at 284M TWD. Fundamentals as of Jul 9, 2026
Our scenario range runs from 6.54 TWD (bear case) to 14.06 TWD (bull case); at 7.88 TWD, the current price sits within that range. The share trades about 35% below its 52-week high and 21% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -44% fair-value upside — at 31%, 4115 screens cheaper than that median.
Key figures & financial health
Figures from reported company fundamentals (EODHD) · as of Jul 9, 2026. TTM = trailing twelve months.
About the company
Sunder Biomedical Tech. Co., Ltd. engages in the manufacture and sale of medical devices. It offers endoscopy vision set, suction irrigation set, smoke filter, endo bag, blood line set for hemodialysis, A.V. fistula needle, I.V. administration, volume control I.V. administration, extension tube. surgical tubing set, PVC compounds for medical application, transducer protector, melt blown nonwoven fabric and mask, and protective goggles, as well as components comprising caps for dialyzer adaptor and for female luer lock. The company was founded in 1998 and is headquartered in Yúnlín, Taiwan.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Sunder Biomedical Tech. Co reported revenue of 753M TWD in FY2025 versus 1.1B TWD in FY2021, a compound −9.8%/yr. Reported net income was −16.3M TWD in FY2025.
Is 4115 fairly valued? → Check now
Similar stocks
10 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate (as of Jul 9, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Intuitive Surgical, Inc ISRG | $402.95 | $182.39 | -55% |
| EssilorLuxottica Société anonyme ESLOF | $205.86 | $114.90 | -44% |
| HOYA Corporation HOCPY | $162.33 | $101.00 | -38% |
| Medline Inc MDLN | $33.61 | $31.78 | -5% |
| Becton, Dickinson and Company BDX | $147.79 | $124.26 | -16% |
| Alcon Inc ALC | $66.11 | $36.99 | -44% |
| ResMed Inc R1MD34 | R$253.26 | R$41.40 | -84% |
| West Pharmaceutical Services, Inc WST | $329.71 | $137.28 | -58% |
| Terumo Corporation TRUMF | $14.62 | $12.65 | -13% |
| Straumann Holding SAUHY | $12.68 | $5.49 | -57% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Sunder Biomedical Tech. Co (4115) undervalued?
What is the fair value of 4115?
What is the quality score of 4115?
What is the net profit margin of 4115?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.